University of Arizona College of Medicine-Phoenix, Department of Basic Medical Sciences, Phoenix, AZ 85004-2157, United States.
Physiol Behav. 2012 Dec 25;108:6-12. doi: 10.1016/j.physbeh.2012.07.010. Epub 2012 Aug 2.
Synthetic glucocorticoids (GC) have been used to promote lung development in preterm infants, thereby decreasing respiratory distress syndrome and mortality, yet, concern has arisen from reports that such treatment predisposes individuals to disease in adulthood. Given the variety of preclinical studies that show metabolic and behavioral abnormalities in adulthood following fetal exposure to synthetic GC, we examined the effect of in utero exposure to the synthetic GC, dexamethasone (DEX), on hypothalamic expression of thyrotropin-releasing hormone (TRH) a central neuropeptide involved in mediating behavior and metabolic balance. Pregnant Sprague-Dawley rats were administered 0.4mg/kg DEX on gestational days 18-21. As adults (postnatal day (PD) 60), the offspring were fitted with temperature sensing transmitters allowing real-time monitoring of core body temperature (CBT) across the 24h light dark period. This revealed a significant decrease in CBT throughout the day in prenatal DEX-treated females on estrus and diestrus, but not in male offspring. The reduction in CBT by prenatal DEX exposure was accompanied by a significant decrease in the expression of Trh transcript in the paraventricular nucleus of the hypothalamus (PVN) of female rats at PD 60 and this effect was also present on PD7. There was also a female-specific reduction in the number of preproTRH-immunoreactive (ir) neurons in the PVN, with ppTRH-ir nerve fibers decreases that were present in both male and female offspring. No changes in thyroid hormone (triiodothyronine, T3; thyroxine, T4) were observed in adult offspring, but during development, both males and females (PD14) had lower T3 and T4 levels. These data indicate abnormal expression of TRH results from fetal DEX exposure during late gestation, possibly explaining the decreased CBT observed in the female offspring.
合成糖皮质激素(GC)已被用于促进早产儿的肺发育,从而降低呼吸窘迫综合征和死亡率,但有报道称,这种治疗会使个体在成年后易患某些疾病,这引起了人们的关注。鉴于大量的临床前研究表明,胎儿暴露于合成 GC 会导致成年后出现代谢和行为异常,我们研究了宫内暴露于合成 GC 地塞米松(DEX)对参与调节行为和代谢平衡的下丘脑促甲状腺素释放激素(TRH)表达的影响。妊娠 Sprague-Dawley 大鼠在妊娠第 18-21 天给予 0.4mg/kg DEX。作为成年人(出生后第 60 天),后代被安装体温传感器,允许实时监测 24 小时光暗周期中的核心体温(CBT)。这表明,在发情期和发情间期,产前 DEX 处理的雌性后代的 CBT 在全天都显著降低,但雄性后代则没有。产前 DEX 暴露导致 CBT 降低,同时下丘脑室旁核(PVN)中 Trh 转录物的表达也显著降低,这种影响在 PD7 时也存在。在雌性大鼠的 PVN 中,也出现了特定于雌性的 preproTRH-免疫反应(ir)神经元数量减少,ppTRH-ir 神经纤维减少,雄性和雌性后代都存在这种情况。在成年后代中未观察到甲状腺激素(三碘甲状腺原氨酸,T3;甲状腺素,T4)的变化,但在发育过程中,雄性和雌性(PD14)都具有较低的 T3 和 T4 水平。这些数据表明,TRH 的异常表达是由于晚期妊娠期间胎儿 DEX 暴露引起的,这可能解释了雌性后代观察到的 CBT 降低。